Laura M. Alcantara
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Systematic identification of bacterial factors driving Staphylococcus aureus intracellular lifestyle in non-professional phagocytes.
Journal: Nature communications
Published: August 29, 2025
Drug Repurposing in Chagas Disease: Chloroquine Potentiates Benznidazole Activity against Trypanosoma cruzi In Vitro and In Vivo.
Journal: Antimicrobial agents and chemotherapy
Published: October 31, 2022
Microscopy-based phenotypic profiling of infection by Staphylococcus aureus clinical isolates reveals intracellular lifestyle as a prevalent feature.
Journal: Nature communications
Published: August 04, 2022
Cyclophilin 19 secreted in the host cell cytosol by Trypanosoma cruzi promotes ROS production required for parasite growth.
Journal: Cellular microbiology
Published: July 19, 2020
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.
Journal: Molecules (Basel, Switzerland)
Published: May 08, 2020
Identification of Inhibitors to Trypanosoma cruzi Sirtuins Based on Compounds Developed to Human Enzymes.
Journal: International journal of molecular sciences
Published: March 18, 2020
Quantification of Parasite Loads by Automated Microscopic Image Analysis.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: April 14, 2019
Drug Discovery for Chagas Disease: Impact of Different Host Cell Lines on Assay Performance and Hit Compound Selection.
Journal: Tropical medicine and infectious disease
Published: March 19, 2019
Challenges in drug discovery targeting TriTryp diseases with an emphasis on leishmaniasis.
Journal: International journal for parasitology. Drugs and drug resistance
Published: May 28, 2018
Aryl thiosemicarbazones for the treatment of trypanosomatidic infections.
Journal: European journal of medicinal chemistry
Published: August 15, 2017
Computer-aided discovery of two novel chalcone-like compounds active and selective against Leishmania infantum.
Journal: Bioorganic & medicinal chemistry letters
Published: February 15, 2017
Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity.
Journal: Molecules (Basel, Switzerland)
Published: February 07, 2017
Last Updated: 09/26/2026